Skip to main content

Table 2 Patients receiving invasive procedures, time to management decision, and diagnostic procedures for the Pre-EBUS cohort compared to the Post-EBUS cohort

From: Impact of the introduction of EBUS on time to management decision, complications, and invasive modalities used to diagnose and stage lung cancer: a pragmatic pre-post study

 

Pre-EBUS cohort (n = 234)

Post-EBUS cohort (n = 326)

p

 

n (%)a

n (%)a

 

Invasive procedures

   

 Bronchoscopy

135 (57.7)

131 (40.2)

<0.001**

 CT-TTNA

92 (39.3)

95 (29.1)

0.012*

 EBUS

0 (0)

90 (27.6)

<0.001**

 Thoracentesis

26 (11.1)

24 (7.4)

0.125

 Other invasive procedures

30 (12.8)

47 (14.4)

0.588

 Other surgical procedures

9 (3.8)

13 (4.0)

0.932

 Mediastinoscopy

1 (0.4)

3 (0.9)

0.644d

Time to management decisionc

   

  ≤ 28 days

154 (66.7)

245 (75.9)

 

  > 28 days

77 (33.3)

78 (24.1)

0.018*

 

Median (IQR)

Median (IQR)

 

Time to management decision (days)c

17 (24)

13 (21)

0.070d

Number of invasive diagnostic proceduresb

1 (0)

1 (0)

0.842e

  1. Thoracentesis: thoracentesis, pleural effusion drainage, pleural biopsy
  2. Other invasive procedures: FNA, US-FNA, EUS-FNA, biopsy other, CT biopsy other
  3. Other surgical therapeutic/diagnostic procedures: surgery for brain metastasis, bone marrow trephine, spinal lesions
  4. *p < 0.05, **p < 0.01
  5. aNumber of patients
  6. bNumber per patient
  7. cExcludes 6 patients with no date of presentation available – unable to establish time to management decision
  8. dFisher’s exact test
  9. eMann–Whitney U test; all other tests except d are Pearson’s chi squared test